MoneyWorks4Me

Aarti Pharmalabs informs about board meeting

28 Jan 2025 Evaluate
Aarti Pharmalabs has informed that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 to consider and approve Audited Financial Results of the Company for the quarter and nine-months ended December 31, 2024 after these results are reviewed by the Audit Committee of the Board; Declaration of Interim Dividend, if any, on the equity share capital of the Company for the Financial Year 2024-25. 

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

867.75 0.00 (0.00%)
03-Sep-2026 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1933.00
Dr. Reddys Labs. 1160.05
Cipla 1407.50
Lupin 2170.00
Zydus Lifesciences 1151.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: